Randomized, double-blind phase II/III study of first-line paclitaxel (P) plus carboplatin (C) in combination with vorinostat or placebo in patients with advanced non-small-cell lung cancer (NSCLC)
Other conference paper


Times Cited
Web of Science7WOS source URL (as at 30/05/2020) Click here for the latest count
Altmetrics Information
.

Other information
All Author(s) ListBelani C, Ramalingam S, Kalemkerian G, Mok T, Rosell R, Ahn MJ, Sun L, Gates M, Lubiniecki GM, Govindan R
Name of Conference15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology
Start Date of Conference20/09/2009
End Date of Conference24/09/2009
Place of ConferenceBerlin
Country/Region of ConferenceGermany
Journal nameEJC Supplements
Detailed descriptionorganized by European Society of Medical Oncology,
Year2009
Month9
Day1
Volume Number7
Issue Number2
PublisherPERGAMON-ELSEVIER SCIENCE LTD
Pages507 - 507
ISSN1359-6349
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology

Last updated on 2020-31-05 at 01:46